Cargando…
Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study
BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immuno...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771186/ https://www.ncbi.nlm.nih.gov/pubmed/31579378 http://dx.doi.org/10.4103/njs.NJS_17_18 |
_version_ | 1783455644668395520 |
---|---|
author | Panda, Abikshyeet Bandyopadhyay, Alokenath Mohiddin, Gouse Raghuvanshi, Malvika Sahoo, Sanjay Kumar Bhuyan, Lipsa |
author_facet | Panda, Abikshyeet Bandyopadhyay, Alokenath Mohiddin, Gouse Raghuvanshi, Malvika Sahoo, Sanjay Kumar Bhuyan, Lipsa |
author_sort | Panda, Abikshyeet |
collection | PubMed |
description | BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immunohistochemistry and to describe the relationship between increased metabolic status and the grades of OSCC. MATERIALS AND METHODS: This is cross-sectional study with 76 formalin-fixed paraffin-embedded tissue blocks of OSCC, obtained from the archives of the department. All the cases were scored using Bryne's grading system by three oral pathologists independently. The tissue sections were then stained using immunohistochemistry with anti-GLUT-1 rabbit monoclonal antibody. RESULTS: Staining intensity and localization of positively stained slides were evaluated. Overall, a significant correlation between Bryne's histopathological grading system for OSCC and GLUT-1 immunohistochemical expression was observed. Thus, high GLUT-1 expressions are observed with increasing grades of OSCC. CONCLUSION: This study shows that a significant positive correlation exists between GLUT-1 immunoexpression and histological grading of OSCC. Thus, GLUT-1 expression can be used as a diagnostic adjunct and prognostic marker for OSCC patients. |
format | Online Article Text |
id | pubmed-6771186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67711862019-10-02 Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study Panda, Abikshyeet Bandyopadhyay, Alokenath Mohiddin, Gouse Raghuvanshi, Malvika Sahoo, Sanjay Kumar Bhuyan, Lipsa Niger J Surg Original Article BACKGROUND: Glucose transporter-1 (GLUT-1) is a GLUT protein whose expression is upregulated in malignant cells where enhanced uptake of glucose is observed. AIM: The aim of this study is to evaluate the expression of GLUT-1 protein in oral squamous cell carcinoma (OSCC) tissue sections using immunohistochemistry and to describe the relationship between increased metabolic status and the grades of OSCC. MATERIALS AND METHODS: This is cross-sectional study with 76 formalin-fixed paraffin-embedded tissue blocks of OSCC, obtained from the archives of the department. All the cases were scored using Bryne's grading system by three oral pathologists independently. The tissue sections were then stained using immunohistochemistry with anti-GLUT-1 rabbit monoclonal antibody. RESULTS: Staining intensity and localization of positively stained slides were evaluated. Overall, a significant correlation between Bryne's histopathological grading system for OSCC and GLUT-1 immunohistochemical expression was observed. Thus, high GLUT-1 expressions are observed with increasing grades of OSCC. CONCLUSION: This study shows that a significant positive correlation exists between GLUT-1 immunoexpression and histological grading of OSCC. Thus, GLUT-1 expression can be used as a diagnostic adjunct and prognostic marker for OSCC patients. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6771186/ /pubmed/31579378 http://dx.doi.org/10.4103/njs.NJS_17_18 Text en Copyright: © 2019 Nigerian Journal of Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Panda, Abikshyeet Bandyopadhyay, Alokenath Mohiddin, Gouse Raghuvanshi, Malvika Sahoo, Sanjay Kumar Bhuyan, Lipsa Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title | Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title_full | Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title_fullStr | Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title_full_unstemmed | Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title_short | Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study |
title_sort | can increased metabolic status be a grading tool for oral squamous cell carcinoma? a glucose transporter 1 immunoexpression study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771186/ https://www.ncbi.nlm.nih.gov/pubmed/31579378 http://dx.doi.org/10.4103/njs.NJS_17_18 |
work_keys_str_mv | AT pandaabikshyeet canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy AT bandyopadhyayalokenath canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy AT mohiddingouse canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy AT raghuvanshimalvika canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy AT sahoosanjaykumar canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy AT bhuyanlipsa canincreasedmetabolicstatusbeagradingtoolfororalsquamouscellcarcinomaaglucosetransporter1immunoexpressionstudy |